Laser treatment for open-angle glaucoma results
Part of Eyes & vision clinical trials.
This trial tests how well a laser treatment called selective laser trabeculoplasty works in people with open-angle glaucoma. It looks at results over 12 months to see if it helps lower eye pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have open-angle glaucoma in both eyes and be scheduled for laser treatment in both eyes.
- Your eye pressure needs to be above 21 mmHg (millimeters of mercury).
- You cannot have uveitis (inflammation inside the eye), angle-closure glaucoma, or congenital glaucoma (glaucoma present at birth).
- You must be able to return for checkups at 3, 6, and 12 months after treatment.
- You cannot have had any eye surgery in the past, except for routine cataract removal done at least 6 months ago.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
This study tests whether a laser treatment helps keep eye pressure stable in people with early glaucoma or high eye pressure who have not used any eye drops or medications before. It may be a good option if you are looking for a treatment that doesn't require daily eye drops.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This study follows patients over time to see how well different glaucoma treatments (medications, laser, or surgery) work. It may help doctors learn which treatments are best for managing glaucoma and high eye pressure.
This trial compares two first treatments—laser therapy (SLT) or daily eye drops (latanoprost)—to lower eye pressure in people newly diagnosed with open-angle glaucoma or high eye pressure. It aims to find which approach works better as an initial therapy.
This study compares a new way of doing laser treatment for open-angle glaucoma versus the standard method. The goal is to see which approach works better at lowering eye pressure and protecting vision.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.